REVATIO 10 mg/ml, poudre pour suspension buvable

( ARTG ) Oral REVATIO is for the treatment of patients with pulmonary arterial hypertension classified as WHO functional classes II and III, to improve exercise capacity. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.,REVATIO solution for injection is for the treatment of adult patients with pulmonary arterial hypertension who are currently prescribed oral REVATIO and who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.,The efficacy of REVATIO has not been evaluated in patients currently on bosentan therapy.